First PREMIER Bank’s GSK GSK Stock Holding History

First PREMIER Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$232K	Buy	4,433 +140	+3%	+$7.4K	0.04%	159
2026 Q1	$237K	Sell	4,293 -440	-9%	-$23.8K	0.05%	151
2025 Q4	$232K	Sell	4,733 -161	-3%	-$7.51K	0.05%	149
2025 Q3	$211K	Buy	4,894 +235	+5%	+$9.18K	0.05%	152
2025 Q2	$179K	Hold	4,659	–	–	0.04%	158
2025 Q1	$181K	Buy	4,659 +286	+7%	+$10.5K	0.05%	151
2024 Q4	$148K	Buy	4,373 +160	+4%	+$5.76K	0.04%	162
2024 Q3	$172K	Hold	4,213	–	–	0.04%	158
2024 Q2	$163K	Sell	4,213 -1,012	-19%	-$42.6K	0.04%	158
2024 Q1	$224K	Sell	5,225 -377	-7%	-$15.5K	0.06%	144
2023 Q4	$208K	Hold	5,602	–	–	0.06%	145
2023 Q3	$203K	Sell	5,602 -746	-12%	-$26.5K	0.06%	144
2023 Q2	$225K	Sell	6,348 -720	-10%	-$25.8K	0.06%	143
2023 Q1	$251K	Buy	7,068 +450	+7%	+$15.7K	0.07%	135
2022 Q4	$232K	Buy	6,618 +970	+17%	+$32.3K	0.07%	135
2022 Q3	$166K	Sell	5,648 -1	-0%	-$38	0.05%	145
2022 Q2	$308K	Sell	5,649 -18	-0.3%	-$994	0.09%	121
2022 Q1	$309K	Buy	5,667 +514	+10%	+$27.9K	0.08%	120
2021 Q4	$284K	Buy	5,153 +23	+0.4%	+$1.2K	0.07%	127
2021 Q3	$245K	Buy	5,130 +208	+4%	+$10.4K	0.07%	128
2021 Q2	$245K	Buy	4,922 +280	+6%	+$13.5K	0.07%	126
2021 Q1	$206K	Buy	4,642 +920	+25%	+$41.8K	0.07%	122
2020 Q4	$172K	Buy	3,722 +120	+3%	+$5.51K	0.07%	120
2020 Q3	$170K	Hold	3,602	–	–	0.07%	118
2020 Q2	$184K	Sell	3,602 -128	-3%	-$6.57K	0.09%	112
2020 Q1	$177K	Sell	3,730 -160	-4%	-$8.54K	0.1%	106
2019 Q4	$229K	Buy	3,890 +16	+0.4%	+$890	0.11%	108
2019 Q3	$207K	Hold	3,874	–	–	0.11%	104
2019 Q2	$193K	Sell	3,874 -596	-13%	-$29.9K	0.11%	101
2019 Q1	$233K	Hold	4,470	–	–	0.13%	98
2018 Q4	$214K	Buy	4,470 +55	+1%	+$2.71K	0.14%	93
2018 Q3	$221K	Buy	4,415 +866	+24%	+$44K	0.14%	89
2018 Q2	$178K	Hold	3,549	–	–	0.12%	93
2018 Q1	$173K	Buy	3,549 +836	+31%	+$38.9K	0.13%	93
2017 Q4	$121K	Sell	2,713 -3,917	-59%	-$181K	0.08%	103
2017 Q3	$337K	Buy	6,630 +796	+14%	+$40.4K	0.24%	74
2017 Q2	$314K	Buy	5,834 +180	+3%	+$9.6K	0.24%	75
2017 Q1	$298K	Hold	5,654	–	–	0.23%	74
2016 Q4	$273K	Hold	5,654	–	–	0.21%	78
2016 Q3	$305K	Hold	5,654	–	–	0.23%	75
2016 Q2	$306K	Hold	5,654	–	–	0.23%	66
2016 Q1	$286K	Buy	5,654 +148	+3%	+$7.37K	0.23%	67
2015 Q4	$278K	Buy	+5,506	New	+$281K	0.24%	65

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

First PREMIER Bank's GSK Position: Q2 2026 in Review

First PREMIER Bank increased its GSK (GSK) stake by 3.3% in Q2 2026, buying an estimated $7.4K and bringing the position to 4,433 shares worth $232K. The position accounts for 0.04% of the portfolio, ranked #159.

First PREMIER Bank first reported a position in GSK in Q4 2015 and has held it in 43 quarters since. The position peaked at $337K in Q3 2017. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

First PREMIER Bank held 4,433 shares of GSK worth $232K as of Q2 2026.
First PREMIER Bank bought 140 GSK shares in Q2 2026, an estimated $7.4K.
GSK made up 0.04% of First PREMIER Bank's portfolio in Q2 2026, its #159 holding.
First PREMIER Bank first reported a position in GSK in Q4 2015 and has held it in 43 quarters since.
First PREMIER Bank's GSK position peaked at $337K in Q3 2017.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on First PREMIER Bank's 13F filing for Q2 2026, filed 15 Jul 2026.